PARP inhibitors as first-line maintenance therapy in ovarian cancer: recommendations from an expert panel from Brazil

PARP inhibitors as first-line maintenance therapy in ovarian cancer: recommendations from an expert panel from Brazil

To report consensus recommendations on the current role of poly(ADP-ribose) polymerase (PARP) inhibitors in the front-line management of patients with epithelial ovarian cancer (EOC) in the healthcare setting of Brazil. The expert panel convened in March 2021 and comprised 20 medical oncologists foc...

Full description

Saved in:
Bibliographic Details
Main Authors: Aknar FC Calabrich, Daniele Xavier Assad, Graziela Dal-Molin, Andreia C Melo, Angelica Nogueira-Rodrigues, Karime Kalil, Andrea PG Guimarães, Michelle Samora Almeida, Carla Rameri de Azevedo, Daniela de Freitas, Alessandra Menezes Morelle, Ana Carolina Leite, Marcela Crosara, João Soares Nunes, Poliana Signorini, Eduardo Cronemberger, Rachel Cossetti, Rodrigo Guindalini, Eduardo Paulino, Fernando C Maluf
Format: Article
Language:English
Published: Thieme Revinter Publicações Ltda. 2023-04-01
Series:Brazilian Journal of Oncology
Subjects:
carcinoma
ovarian epithelial
poly(adp-ribose) polymerase inhibitors
consensus
Online Access:https://www.brazilianjournalofoncology.com.br/details/238/en-US/parp-inhibitors-as-first-line-maintenance-therapy-in-ovarian-cancer--recommendations-from-an-expert-panel-from-brazil
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.brazilianjournalofoncology.com.br/details/238/en-US/parp-inhibitors-as-first-line-maintenance-therapy-in-ovarian-cancer--recommendations-from-an-expert-panel-from-brazil

Similar Items